Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer

PURPOSE: To explore if bexarotene (BEX) synergistically enhances docetaxel (DTX) cytotoxicity in castration-resistant prostate cancer cell lines. MATERIALS AND METHODS: MTT assay was used to measure the cytotoxic effect of DTX and BEX on castration-resistant prostate cancer (CRPC) cell proliferation...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Danyang, Wang, Huan, Zheng, Qiming, Cheng, Sheng, Xu, Liwei, Wang, Mingchao, Li, Gong H, Xia, Li Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768013/
https://www.ncbi.nlm.nih.gov/pubmed/31576145
http://dx.doi.org/10.2147/OTT.S209307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768013/
https://www.ncbi.nlm.nih.gov/pubmed/31576145
http://dx.doi.org/10.2147/OTT.S209307

Ejemplares similares